4//SEC Filing
Shukla Sanjay 4
Accession 0001209191-23-007362
CIK 0001339970other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 6:57 PM ET
Size
7.3 KB
Accession
0001209191-23-007362
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Shukla Sanjay
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common stock
2023-02-03+10,375→ 61,173 total - Exercise/Conversion
Restricted Stock Unit
2023-02-03−10,375→ 31,125 total→ Common Stock (10,375 underlying)
Footnotes (3)
- [F1]Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on February 3, 2022.
- [F2]Restricted stock units convert into common stock on a one-for-one basis.
- [F3]The RSUs vest in four equal annual installments beginning on February 3, 2023, such that the RSUs will fully vest on February 3, 2026. The RSUs are subject to accelerated vesting upon termination without cause upon a change of control of the Issuer.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001671026
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 6:57 PM ET
- Size
- 7.3 KB